Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

DISOPYRAMIDE 100 MG CAPSULE

disopyramide phosphate
$0.7926per EA

Strength

100 mg/1

Manufacturer

Mylan Pharmaceuticals Inc.

NDC

59762038601

Classification

Generic

Dosage Form

CAPSULE, GELATIN COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

DISOPYRAMIDE PHOSPHATE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA017447

On Market Since

4/23/2019

Pharmacological Classes

Antiarrhythmic

Price History

1W

0.0%

1M

+7.5%

3M

+11.0%

6M

-24.8%

1Y

+8.6%

3Y

-49.4%

5Y

-38.9%

All

-49.8%

Generic Alternatives

1 alternative • Same active ingredient

NORPACE CR 100 MG CAPSULE
Brand
00025273231•Pfizer Inc.
$4.1412
+422% more

Related Drugs

Same classification

BURN RELIEF 0.5% SPRAY
Generic
70000062401•Cardinal Health
$0.0276
per GM
BURN RELIEF 0.5% SPRAY
Generic
46122055528•AmerisourceBergen
$0.0283
per GM
LIDOCAINE HCL 1% VIAL
Generic
00409427602•Hospira Inc.
$0.0397
per ML
GNP LIDOCAINE HCL 4% CREAM
Generic
46122061410•AmerisourceBergen
$0.0514
per GM
LIDOCAINE HCL 4% CREAM
Generic
70000009801•Cardinal Health
$0.0514
per GM
LIDOCAINE HCL 2% VIAL
Generic
00409427702•Hospira Inc.
$0.0569
per ML
LIDOCAINE HCL 1% 300 MG/30 ML
Generic
55150016300•Eugia US LLC
$0.0689
per ML
LIDOCAINE HCL 1% 300 MG/30 ML
Generic
55150016330•Eugia US LLC
$0.0689
per ML
SOTALOL 80 MG TABLET
Generic
00093106101•Teva Pharmaceuticals USA Inc.
$0.0694
per EA
SOTALOL 80 MG TABLET
Generic
00904714361•Major Pharmaceuticals
$0.0694
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy